Globus Medical Depreciation & Amortization Growth & History (GMED)
Globus Medical's depreciation and amortization was $276.8M for fiscal 2025.
View full Globus Medical company overviewGlobus Medical annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $276.8M | $23.5M | +9.26% |
| 2024 | 2024-12-31 | $253.4M | $107.9M | +74.12% |
| 2023 | 2023-12-31 | $145.5M | $77.3M | +113.22% |
| 2022 | 2022-12-31 | $68.3M | −$1.6M | −2.31% |
| 2021 | 2021-12-31 | $69.9M | $7.0M | +11.12% |
| 2020 | 2020-12-31 | $62.9M | $10.1M | +19.23% |
| 2019 | 2019-12-31 | $52.7M | $11.1M | +26.67% |
| 2018 | 2018-12-31 | $41.6M | −$437,000 | −1.04% |
| 2017 | 2017-12-31 | $42.1M | $3.3M | +8.50% |
| 2016 | 2016-12-31 | $38.8M | $14.7M | +60.98% |
| 2015 | 2015-12-31 | $24.1M | $2.3M | +10.71% |
| 2014 | 2014-12-31 | $21.8M | $2.4M | +12.15% |
| 2013 | 2013-12-31 | $19.4M | $1.3M | +7.12% |
| 2012 | 2012-12-31 | $18.1M | $1.2M | +6.84% |
| 2011 | 2011-12-31 | $16.9M | $1.8M | +11.54% |
| 2010 | 2010-12-31 | $15.2M | — | — |
Globus Medical quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $69.5M | −$1.1M | −1.60% |
| Q1 2026 | 2026-03-31 | $69.9M | $4.2M | +6.40% |
| Q4 2025 | 2025-12-31 | $69.0M | — | — |
| Q3 2025 | 2025-09-30 | $71.5M | $4.6M | +6.87% |
| Q2 2025 | 2025-06-30 | $70.6M | $7.0M | +11.08% |
| Q1 2025 | 2025-03-31 | $65.7M | $10.4M | +18.81% |
| Q3 2024 | 2024-09-30 | $66.9M | $29.6M | +79.06% |
| Q2 2024 | 2024-06-30 | $63.6M | $45.5M | +251.80% |
| Q1 2024 | 2024-03-31 | $55.3M | $37.2M | +205.17% |
| Q3 2023 | 2023-09-30 | $37.4M | $19.8M | +112.70% |
| Q2 2023 | 2023-06-30 | $18.1M | $1.1M | +6.78% |
| Q1 2023 | 2023-03-31 | $18.1M | $1.3M | +7.55% |
| Q3 2022 | 2022-09-30 | $17.6M | $827,000 | +4.94% |
| Q2 2022 | 2022-06-30 | $16.9M | −$2.2M | −11.52% |
| Q1 2022 | 2022-03-31 | $16.8M | −$320,000 | −1.87% |
| Q3 2021 | 2021-09-30 | $16.8M | $450,000 | +2.76% |
| Q2 2021 | 2021-06-30 | $19.1M | $4.0M | +26.68% |
| Q1 2021 | 2021-03-31 | $17.2M | $2.6M | +17.77% |
| Q3 2020 | 2020-09-30 | $16.3M | $2.7M | +20.08% |
| Q2 2020 | 2020-06-30 | $15.1M | $2.2M | +17.44% |
| Q1 2020 | 2020-03-31 | $14.6M | $2.3M | +18.88% |
| Q3 2019 | 2019-09-30 | $13.6M | $3.1M | +29.77% |
| Q2 2019 | 2019-06-30 | $12.9M | $3.1M | +31.79% |
| Q1 2019 | 2019-03-31 | $12.3M | $2.8M | +29.32% |
| Q3 2018 | 2018-09-30 | $10.5M | −$377,000 | −3.48% |
| Q2 2018 | 2018-06-30 | $9.8M | −$938,000 | −8.77% |
| Q1 2018 | 2018-03-31 | $9.5M | −$2.8M | −22.58% |
| Q3 2017 | 2017-09-30 | $10.8M | $3.0M | +38.28% |
| Q2 2017 | 2017-06-30 | $10.7M | $3.7M | +52.31% |
| Q1 2017 | 2017-03-31 | $12.2M | $5.6M | +83.34% |
| Q3 2016 | 2016-09-30 | $7.8M | $1.7M | +28.70% |
| Q2 2016 | 2016-06-30 | $7.0M | $1.1M | +18.92% |
| Q1 2016 | 2016-03-31 | $6.7M | $1.0M | +17.66% |
| Q3 2015 | 2015-09-30 | $6.1M | $717,000 | +13.34% |
| Q2 2015 | 2015-06-30 | $5.9M | $518,000 | +9.62% |
| Q1 2015 | 2015-03-31 | $5.7M | $377,000 | +7.12% |
| Q3 2014 | 2014-09-30 | $5.4M | $514,000 | +10.58% |
| Q2 2014 | 2014-06-30 | $5.4M | $645,000 | +13.60% |
| Q1 2014 | 2014-03-31 | $5.3M | $687,000 | +14.90% |
| Q3 2013 | 2013-09-30 | $4.9M | $247,000 | +5.36% |
| Q2 2013 | 2013-06-30 | $4.7M | $235,000 | +5.21% |
| Q1 2013 | 2013-03-31 | $4.6M | $229,000 | +5.23% |
| Q3 2012 | 2012-09-30 | $4.6M | $286,000 | +6.61% |
| Q2 2012 | 2012-06-30 | $4.5M | — | — |
| Q1 2012 | 2012-03-31 | $4.4M | — | — |
| Q3 2011 | 2011-09-30 | $4.3M | — | — |
Globus Medical depreciation and amortization trends
Over the last five fiscal years, Globus Medical's depreciation and amortization increased from $62.9M to $276.8M, a change of $214.0M. The latest reported quarter, Q2 2026, shows $69.5M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Globus Medical source filings ↗